Market Cap ₹805 Cr.
Stock P/E 17.3
P/B 0.8
Current Price ₹121.2
Book Value ₹ 152.4
Face Value 10
52W High ₹191.7
Dividend Yield 2.06%
52W Low ₹ 114.6
Dhampur Bio Organics Ltd is a company based in India that specializes in the production and marketing of organic and natural products. The company offers a range of organic foods, including sugar, rice, pulses, and spices, as well as organic fertilizers and pesticides. Dhampur Bio Organics Ltd is committed to sustainable agriculture and ethical business practices. The company's products are certified organic and are produced without the use of harmful chemicals or synthetic fertilizers. Founded in 1992, Dhampur Bio Organics Ltd has grown to become a leading producer of organic and natural products in India. The company has a strong focus on research and development, and is constantly innovating to improve its products and processes. Dhampur Bio Organics Ltd is dedicated to promoting a healthier and more sustainable food system, and is committed to providing high-quality, organic products to customers around the world.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 348 | 506 | 496 | 542 | 696 | 921 | 709 | 666 | 425 | 595 |
| Other Income | 0 | 4 | 3 | 6 | 1 | 2 | 2 | 1 | 16 | 5 |
| Total Income | 348 | 510 | 498 | 548 | 697 | 923 | 712 | 666 | 441 | 600 |
| Total Expenditure | 312 | 404 | 464 | 519 | 662 | 805 | 669 | 646 | 429 | 513 |
| Operating Profit | 36 | 106 | 34 | 29 | 35 | 118 | 43 | 20 | 11 | 86 |
| Interest | 3 | 10 | 14 | 9 | 5 | 13 | 13 | 9 | 6 | 18 |
| Depreciation | 8 | 10 | 8 | 9 | 10 | 13 | 11 | 10 | 14 | 14 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 25 | 86 | 12 | 11 | 20 | 92 | 18 | 0 | -8 | 54 |
| Provision for Tax | 7 | 15 | 3 | 3 | 5 | 12 | 6 | 0 | -2 | 15 |
| Profit After Tax | 18 | 71 | 8 | 8 | 15 | 80 | 13 | 0 | -6 | 39 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 18 | 71 | 8 | 8 | 15 | 80 | 13 | 0 | -6 | 39 |
| Adjusted Earnings Per Share | 2.7 | 10.7 | 1.2 | 1.2 | 2.3 | 12.1 | 1.9 | 0 | -0.8 | 5.9 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|
| Net Sales | 0 | 1564 | 2408 | 2395 |
| Other Income | 0 | 8 | 11 | 24 |
| Total Income | 0 | 1572 | 2419 | 2419 |
| Total Expenditure | 0 | 1381 | 2203 | 2257 |
| Operating Profit | -0 | 190 | 216 | 160 |
| Interest | 0 | 30 | 41 | 46 |
| Depreciation | 0 | 31 | 41 | 49 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | 129 | 135 | 64 |
| Provision for Tax | 0 | 27 | 24 | 19 |
| Profit After Tax | -0 | 102 | 111 | 46 |
| Adjustments | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | 102 | 111 | 46 |
| Adjusted Earnings Per Share | -0 | 15.4 | 16.7 | 7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 54% | 0% | 0% | 0% |
| Operating Profit CAGR | 14% | 0% | 0% | 0% |
| PAT CAGR | 9% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -28% | NA% | NA% | NA% |
| ROE Average | 12% | 8% | 8% | 8% |
| ROCE Average | 10% | 7% | 7% | 7% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Shareholder's Funds | 775 | 879 | 989 |
| Minority's Interest | 0 | 0 | 0 |
| Borrowings | 99 | 108 | 169 |
| Other Non-Current Liabilities | 59 | 57 | 61 |
| Total Current Liabilities | 618 | 979 | 881 |
| Total Liabilities | 1551 | 2023 | 2100 |
| Fixed Assets | 631 | 690 | 909 |
| Other Non-Current Assets | 20 | 88 | 43 |
| Total Current Assets | 901 | 1245 | 1147 |
| Total Assets | 1551 | 2023 | 2100 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 23 |
| Cash Flow from Operating Activities | -0 | -246 | 368 |
| Cash Flow from Investing Activities | 0 | -138 | -209 |
| Cash Flow from Financing Activities | 0 | 393 | -78 |
| Net Cash Inflow / Outflow | 0 | 9 | 81 |
| Closing Cash & Cash Equivalent | 0 | 23 | 104 |
| # | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Earnings Per Share (Rs) | -0 | 15.41 | 16.73 |
| CEPS(Rs) | -0 | 20.13 | 22.84 |
| DPS(Rs) | 0 | 0 | 3.5 |
| Book NAV/Share(Rs) | 116.73 | 132.32 | 148.93 |
| Core EBITDA Margin(%) | 0 | 11.68 | 7.71 |
| EBIT Margin(%) | 0 | 10.17 | 6.62 |
| Pre Tax Margin(%) | 0 | 8.27 | 5.08 |
| PAT Margin (%) | 0 | 6.54 | 4.19 |
| Cash Profit Margin (%) | 0 | 8.54 | 5.71 |
| ROA(%) | -0 | 5.73 | 5.39 |
| ROE(%) | -0 | 12.38 | 11.9 |
| ROCE(%) | -0 | 11.06 | 10.04 |
| Receivable days | 0 | 24.98 | 17.96 |
| Inventory Days | 0 | 207 | 128.97 |
| Payable days | 0 | 75.24 | 33.05 |
| PER(x) | 0 | 0 | 8.56 |
| Price/Book(x) | 0 | 0 | 0.96 |
| Dividend Yield(%) | 0 | 0 | 2.44 |
| EV/Net Sales(x) | 0 | 0.56 | 0.68 |
| EV/Core EBITDA(x) | 0 | 4.57 | 7.62 |
| Net Sales Growth(%) | 0 | 0 | 53.93 |
| EBIT Growth(%) | 0 | 0 | 10.38 |
| PAT Growth(%) | 0 | 0 | 8.57 |
| EPS Growth(%) | 0 | 0 | 8.57 |
| Debt/Equity(x) | 0.51 | 0.94 | 0.81 |
| Current Ratio(x) | 1.46 | 1.27 | 1.3 |
| Quick Ratio(x) | 0.3 | 0.19 | 0.37 |
| Interest Cover(x) | 0 | 5.36 | 4.3 |
| Total Debt/Mcap(x) | 0 | 0 | 0.84 |
| # | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Promoter | 49.08 | 49.08 | 50.22 | 50.22 | 50.44 | 50.44 | 50.63 | 50.78 |
| FII | 8.55 | 7.37 | 6.63 | 5.34 | 4.81 | 4.83 | 3.42 | 1.95 |
| DII | 0.49 | 0.59 | 0.49 | 0.47 | 0.45 | 0.45 | 0.45 | 0.45 |
| Public | 41.88 | 42.96 | 42.67 | 43.98 | 44.3 | 44.27 | 45.5 | 46.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Promoter | 3.26 | 3.26 | 3.33 | 3.33 | 3.35 | 3.35 | 3.36 | 3.37 |
| FII | 0.57 | 0.49 | 0.44 | 0.35 | 0.32 | 0.32 | 0.23 | 0.13 |
| DII | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Public | 2.78 | 2.85 | 2.83 | 2.92 | 2.94 | 2.94 | 3.02 | 3.11 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6.64 | 6.64 | 6.64 | 6.64 | 6.64 | 6.64 | 6.64 | 6.64 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
